F048 - Coding and Office Management
Saturday, March 2; 9:00 AM - 11:00 AM
Following this course, the attendee should be able to:
- Determine when evaluation and management services qualify for modifier 25 billing.
- Apply new and revised CPT coding paradigms to appropriately code for services provided.
- Identify management techniques for optimizing his/her dermatology practice.
This session will provide practical office management, coding, billing and online presence tips for implementation in various practice settings. It is designed as an audience interactive process that will involve the attendees in the presentations as well as with subsequent questions and answers.
The session is appropriate for health professionals practicing in any dermatology practice environment.
This activity has been approved by the American Board of Dermatology (ABD) for up to 20 MOC Component 2 Self-Assessment points. For more information about MOC, please visit the ABD website at www.abderm.org.
- Dinehart, Scott M., MD: American Board of Dermatology Physician Assistants (ABDPA) – B(NC); Arkansas Dermatology – F(S); Castle Biosciences, Inc – A(H); Genentech, Inc. – A(H), SP(H); Regeneron – A(H), SP(H); Verrica Pharmaceuticals Inc – C(H);
- Eastern, Joseph S., MD: AbbVie – A(H), I(Grants/Research Funding), SP(H); Celgene Corporation – SP(H); Galderma Laboratories, L.P. – A(H), SP(H); Janssen Pharmaceuticals, Inc – I(Grants/Research Funding); Janssen-Ortho Inc. – A(H); Leo Pharma Inc – A(H); Medimetriks Pharmaceuticals, Inc. – A(H); Novartis Pharmaceuticals Corp. – A(H), SP(H); Pfizer Inc. – SP(H); sanofi-aventis – SP(H);
- Kaufmann, Mark D., MD: BioPharmX – C(Fees); Castle Biosciences, Inc – C(Fees); Cutanea Life Sciences – C(Fees); Dermira – C(Fees); Galderma USA – C(Fees); IntraDerm Pharmaceuticals – C(Fees); ISDIN – C(Fees); Klara/Goderma, Inc. – C(SO); L'Oreal USA Inc. – C(Fees); La Roche-Posay Laboratorie Pharmaceutique – C(Fees); Modernizing Medicine – C(SO); MoleSafe, Inc. – O(Fees), O(ST); Ortho Dermatologics – C(Fees); Promius Pharma, LLC – C(Fees); SciBASE – C(Fees); Sensus Healthcare – A(H); Sun Pharmaceutical Industries Ltd. – C(Fees); UCB – C(Fees);
- Miller, Alexander, MD: no financial relationships exist with commercial interests.
- Rogers, Howard Wooding, MD: no financial relationships exist with commercial interests.
Saturday, March 2
Dr. Miller / Contemporary Coding Issues
Dr. Rogers / Don't Get Burned by Modifier 25
Dr. Kaufmann / What the RUC
Dr. Dinehart / Practice Management Tips
Dr. Eastern / Protecting Your Online Reputation